COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
Authors
Keywords
-
Journal
Lancet Rheumatology
Volume 3, Issue 10, Pages e724-e736
Publisher
Elsevier BV
Online
2021-08-29
DOI
10.1016/s2665-9913(21)00247-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 – Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments
- (2021) J.M. Gelfand et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2021) Anja Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al
- (2021) Martin Schäfer et al. ANNALS OF THE RHEUMATIC DISEASES
- The racial/ethnic and sociocultural aspects of the pandemic in rheumatology
- (2021) Tiffany Taylor et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study
- (2021) Mohamed Attauabi et al. JOURNAL OF AUTOIMMUNITY
- SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response
- (2021) Michael Markus Bonelli et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases
- (2021) Robert Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease
- (2021) A. Al‐Janabi et al. BRITISH JOURNAL OF DERMATOLOGY
- Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals
- (2021) Bryant R. England et al. Arthritis & Rheumatology
- Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
- (2021) Giuseppe A Ramirez et al. ANNALS OF THE RHEUMATIC DISEASES
- High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
- (2021) Jake A Ruddy et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
- (2021) Rebecca H Haberman et al. ANNALS OF THE RHEUMATIC DISEASES
- Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
- (2021) Patrícia O. Guimarães et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brief Report: Humoral and cellular immune responses to SARS‐CoV‐2 infection and vaccination in B cell depleted autoimmune patients
- (2021) David Simon et al. Arthritis & Rheumatology
- SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
- (2021) James L Alexander et al. Lancet Gastroenterology & Hepatology
- COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
- (2021) Jérôme Avouac et al. Lancet Rheumatology
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine
- (2020) Emanuele Bozzalla Cassione et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
- (2020) Philippe Guilpain et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- The impact of the COVID ‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience
- (2020) P. Gisondi et al. BRITISH JOURNAL OF DERMATOLOGY
- Biologics increase the risk of SARS ‐ CoV ‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration
- (2020) Giovanni Damiani et al. Dermatologic Therapy
- SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
- (2020) John Gubatan et al. GASTROENTEROLOGY
- Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy
- (2020) Lorenzo Norsa et al. GASTROENTEROLOGY
- Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
- (2020) Erica J. Brenner et al. GASTROENTEROLOGY
- Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease
- (2020) Dana J. Lukin et al. GASTROENTEROLOGY
- Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
- (2020) Cristina Bezzio et al. GUT
- Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
- (2020) Juan F Burgueño et al. INFLAMMATORY BOWEL DISEASES
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis
- (2020) Ennio Giulio Favalli et al. JOURNAL OF RHEUMATOLOGY
- Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
- (2020) Paolo Gisondi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
- (2020) Lorenzo D’Antiga LIVER TRANSPLANTATION
- Implications of COVID-19 for patients with pre-existing digestive diseases
- (2020) Ren Mao et al. Lancet Gastroenterology & Hepatology
- Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
- (2020) Jose L Pablos et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors
- (2020) Vega Jovani et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
- (2020) Hendrik Schulze-Koops et al. ANNALS OF THE RHEUMATIC DISEASES
- Mild COVID-19 in ANCA-associated vasculitis treated with rituximab
- (2020) Silvia Suárez-Díaz et al. ANNALS OF THE RHEUMATIC DISEASES
- Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature
- (2020) Phil‐Robin Tepasse et al. BRITISH JOURNAL OF HAEMATOLOGY
- Biologic agents in psoriasis: our experience during coronavirus infection
- (2020) Davide Strippoli et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce
- (2020) F Magro et al. Journal of Crohns & Colitis
- Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19
- (2020) Marla J Keller et al. Journal of Hospital Medicine
- Severe COVID‐19 outcomes in patients with psoriasis
- (2020) X.T. Lima et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
- (2020) David Simon et al. Nature Communications
- COVID‐19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes
- (2020) Rebecca H. Haberman et al. Arthritis & Rheumatology
- Incidence of COVID‐19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?
- (2020) Ennio Giulio Favalli et al. Arthritis & Rheumatology
- Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy
- (2020) Stefano Piaserico et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis
- (2020) Shintaro Akiyama et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series
- (2020) Clodoveo Ferri et al. CLINICAL RHEUMATOLOGY
- Effect of IBD medications on COVID-19 outcomes: results from an international registry
- (2020) Ryan C Ungaro et al. GUT
- Factors associated with adverse COVID-19 outcomes in patients with psoriasis – insights from a global registry-based study
- (2020) Satveer K. Mahil et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Elevated markers of gut leakage and inflammasome activation in COVID‐19 patients with cardiac involvement
- (2020) H. Hoel et al. JOURNAL OF INTERNAL MEDICINE
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study
- (2020) Jose Luis Rodriguez-Garcia et al. RHEUMATOLOGY
- High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study
- (2020) Jesús Loarce-Martos et al. RHEUMATOLOGY INTERNATIONAL
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence
- (2020) Félicie Costantino et al. JOINT BONE SPINE
- Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy
- (2020) Roberto Berte’ et al. Journal of Crohns & Colitis
- The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Sudabeh Alatab et al. Lancet Gastroenterology & Hepatology
- A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis
- (2018) Sujith Subesinghe et al. JOURNAL OF RHEUMATOLOGY
- Risk of Serious Infection among Patients Receiving Biologics for Chronic Inflammatory Diseases: Usefulness of Administrative Data
- (2018) Luca Quartuccio et al. Journal of Advanced Research
- Psoriasis: classical and emerging comorbidities
- (2015) Maria de Fátima Santos Paim de Oliveira et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance
- (2015) K L Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use
- (2015) Junko Takeshita et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
- (2015) Jasvinder A Singh et al. LANCET
- Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
- (2014) Valentina Germano et al. Journal of Translational Medicine
- The Table 2 Fallacy: Presenting and Interpreting Confounder and Modifier Coefficients
- (2013) D. Westreich et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study
- (2012) William A Blumentals et al. BMC MUSCULOSKELETAL DISORDERS
- The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment
- (2012) J. Listing et al. RHEUMATOLOGY
- The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials
- (2011) Erica D. Dommasch et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
- (2009) Daniel E. Furst SEMINARS IN ARTHRITIS AND RHEUMATISM
- Infections and IBD
- (2008) Peter M Irving et al. Nature clinical practice. Gastroenterology & hepatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now